Literature DB >> 1513853

Effects of bifemelane on discrimination learning of serotonergic-dysfunction rats.

M Nomura1.   

Abstract

To investigate the effect of bifemelane hydrochloride on learning achievements of serotonin-deficient rats, animals were fed with tryptophan-deficient diets and operant type discrimination learning tests were performed. In general, serotonin-deficient rats show hyperactivity. In this study, total number of responses in reverse learning experiments was lower in rats that received 50 mg/kg bifemelane compared to the other serotonin-deficient groups. The ratio of correct responses to the total number of responses revealed low learning achievements in the control and low-dose groups, whereas the ratio in the high-dose group was nearly the same as in normal rats in the final few sessions of both the primary and reverse learning experiments. Throughout this study, the high-dose group showed a better improvement in learning achievement than the low-dose group. Therefore, bifemelane has certain effects on learning achievement from a) the functional activation of the serotonergic nervous system and b) changes in neurotransmitter levels in the brain (e.g., acetylcholine, noradrenaline) and overall energy metabolism.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1513853     DOI: 10.1016/0091-3057(92)90020-g

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  2 in total

1.  Relationship between limbic and cortical 5-HT neurotransmission and acquisition and reversal learning in a go/no-go task in rats.

Authors:  Daiki Masaki; Chihiro Yokoyama; Seijiro Kinoshita; Hideto Tsuchida; Yasuhito Nakatomi; Kanji Yoshimoto; Kenji Fukui
Journal:  Psychopharmacology (Berl)       Date:  2006-10-03       Impact factor: 4.530

Review 2.  Toward a theoretical role for tonic norepinephrine in the orbitofrontal cortex in facilitating flexible learning.

Authors:  Brian F Sadacca; Andrew M Wikenheiser; Geoffrey Schoenbaum
Journal:  Neuroscience       Date:  2016-04-19       Impact factor: 3.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.